Use of Intravenous Iodinated Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation

Matthew S Davenport, Mark A Perazella, Jerry Yee, Jonathan R Dillman, Derek Fine, Robert J McDonald, Roger A Rodby, Carolyn L Wang, Jeffrey C Weinreb, Matthew S Davenport, Mark A Perazella, Jerry Yee, Jonathan R Dillman, Derek Fine, Robert J McDonald, Roger A Rodby, Carolyn L Wang, Jeffrey C Weinreb

Abstract

Intravenous iodinated contrast media are commonly used with CT to evaluate disease and to determine treatment response. The risk of acute kidney injury (AKI) developing in patients with reduced kidney function following exposure to intravenous iodinated contrast media has been overstated. This is due primarily to historic lack of control groups sufficient to separate contrast-induced AKI (CI-AKI; ie, AKI caused by contrast media administration) from contrast-associated AKI (CA-AKI; ie, AKI coincident to contrast media administration). Although the true risk of CI-AKI remains uncertain for patients with severe kidney disease, prophylaxis with intravenous normal saline is indicated for patients who have AKI or an estimated glomerular filtration rate less than 30 mL/min/1.73 m2 who are not undergoing maintenance dialysis. In individual high-risk circumstances, prophylaxis may be considered in patients with an estimated glomerular filtration rate of 30-44 mL/min/1.73 m2 at the discretion of the ordering clinician.

© 2020 The Author(s). Published by Elsevier Inc. on behalf of National Kidney Foundation, Inc. and Radiological Society of North America.

Figures

Figure 1
Figure 1
Image shows Kidney Disease Improving Global Outcomes (KDIGO) staging criteria for acute kidney injury (AKI) and chronic kidney disease (CKD). Urine output criteria for AKI staging were not included. Abbreviations: ACR, albumin creatinine ratio; AER, albumin excretion rate; Cr, creatinine; GFR, glomerular filtration rate.

References

    1. Davenport M.S., Cohan R.H., Ellis J.H. Contrast media controversies in 2015: imaging patients with renal impairment or risk of contrast reaction. AJR Am J Roentgenol. 2015;204(6):1174–1181.
    1. Davenport M.S., Cohan R.H., Khalatbari S., Ellis J.H. The challenges in assessing contrast-induced nephropathy: where are we now? AJR Am J Roentgenol. 2014;202(4):784–789.
    1. Katzberg R.W., Newhouse J.H. Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe? Radiology. 2010;256(1):21–28.
    1. Ehrmann S., Aronson D., Hinson J.S. Contrast-associated acute kidney injury is a myth: Yes. Intensive Care Med. 2018;44(1):104–106.
    1. Weisbord S.D., du Cheryon D. Contrast-associated acute kidney injury is a myth: No. Intensive Care Med. 2018;44(1):107–109.
    1. Kashani K., Levin A., Schetz M. Contrast-associated acute kidney injury is a myth: We are not sure. Intensive Care Med. 2018;44(1):110–114.
    1. Davenport M.S., Khalatbari S., Dillman J.R., Cohan R.H., Caoili E.M., Ellis J.H. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material. Radiology. 2013;267(1):94–105.
    1. Davenport M.S., Khalatbari S., Cohan R.H., Dillman J.R., Myles J.D., Ellis J.H. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. Radiology. 2013;268(3):719–728.
    1. McDonald J.S., McDonald R.J., Comin J. Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. Radiology. 2013;267(1):119–128.
    1. McDonald R.J., McDonald J.S., Bida J.P. Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? Radiology. 2013;267(1):106–118.
    1. McDonald J.S., McDonald R.J., Carter R.E., Katzberg R.W., Kallmes D.F., Williamson E.E. Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. Radiology. 2014;271(1):65–73.
    1. Newhouse J.H., RoyChoudhury A. Quantitating contrast medium-induced nephropathy: controlling the controls. Radiology. 2013;267(1):4–8.
    1. Dekkers I.A., van der Molen A.J. Propensity score matching as a substitute for randomized controlled trials on acute kidney injury after contrast media administration: a systematic review. AJR Am J Roentgenol. 2018;211(4):822–826.
    1. Morris Z.S., Wooding S., Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. 2011;104(12):510–520.
    1. American College of Radiology Manual on contrast media. Version 10.3. Reston, Va: American College of Radiology, 2018.
    1. Nyman U., Ahlkvist J., Aspelin P. Preventing contrast medium-induced acute kidney injury : Side-by-side comparison of Swedish-ESUR guidelines. Eur Radiol. 2018;28(12):5384–5395.
    1. Palevsky P.M., Liu K.D., Brophy P.D. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013;61(5):649–672.
    1. The Royal College of Radiologists . 3rd ed. The Royal College of Radiologists; London, England: 2015. Standards for intravascular contrast administration to adult patients.
    1. Schönenberger E., Martus P., Bosserdt M. Kidney injury after intravenous versus intra-arterial contrast agent in patients suspected of having coronary artery disease: a randomized trial. Radiology. 2019;292(3):664–672.
    1. Rao Q.A., Newhouse J.H. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology. 2006;239(2):392–397.
    1. Section 2: AKI definition. Kidney Int Suppl (2011) 2012;2(1):19–36.
    1. Mehta R.L., Kellum J.A., Shah S.V. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.
    1. Inker L.A., Astor B.C., Fox C.H. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713–735.
    1. Levin A., Stevens P.E. Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2014;85(1):49–61.
    1. Levey A.S. Measurement of renal function in chronic renal disease. Kidney Int. 1990;38(1):167–184.
    1. Faucon A.L., Bobrie G., Clément O. Nephrotoxicity of iodinated contrast media: From pathophysiology to prevention strategies. Eur J Radiol. 2019;116:231–241.
    1. Rosenstock J.L., Gilles E., Geller A.B. Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease. Int Urol Nephrol. 2010;42(4):1049–1054.
    1. Stacul F., Bertolotto M., Thomsen H.S. Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2018;28(2):683–691.
    1. Pahade J.K., LeBedis C.A., Raptopoulos V.D. Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT. AJR Am J Roentgenol. 2011;196(5):1094–1101.
    1. Crowley M.P., Prabhakaran V.N., Gilligan O.M. Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced procedures. Pathol Oncol Res. 2018;24(4):915–919.
    1. Eng J., Subramaniam R.M., Wilson R.F. Agency for Healthcare Research and Quality (US); Rockville, Md: 2015. Contrast-induced nephropathy: comparative effects of different contrast media. Report No. 15(16)-EHC022-EF.
    1. Subramaniam R.M., Wilson R.F., Turban S. Agency for Healthcare Research and Quality (US); Rockville, Md: 2016. Contrast-induced nephropathy: comparative effectiveness of preventive measures. Report No. 15(16)-EHC023-EF.
    1. Weisbord S.D., Palevsky P.M. Prevention of contrast-induced nephropathy with volume expansion. Clin J Am Soc Nephrol. 2008;3(1):273–280.
    1. Nijssen E.C., Nelemans P.J., Rennenberg R.J., Theunissen R.A., van Ommen V., Wildberger J.E. Prophylaxis in High-Risk Patients With eGFR < 30 mL/min/1.73 m2: Get the Balance Right. Invest Radiol. 2019;54(9):580–588.
    1. Nijssen E.C., Rennenberg R.J., Nelemans P.J. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet. 2017;389(10076):1312–1322.
    1. Ellis J.H., Khalatbari S., Yosef M., Cohan R.H., Davenport M.S. Influence of clinical factors on risk of contrast-induced nephrotoxicity from IV iodinated low-osmolality contrast material in patients with a low estimated glomerular filtration rate. AJR Am J Roentgenol. 2019;213(5):W188–W193.
    1. van der Molen A.J., Reimer P., Dekkers I.A. Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol. 2018;28(7):2856–2869.
    1. Cheungpasitporn W., Thongprayoon C., Brabec B.A., Edmonds P.J., O’Corragain O.A., Erickson S.B. Oral hydration for prevention of contrast-induced acute kidney injury in elective radiological procedures: a systematic review and meta-analysis of randomized controlled trials. N Am J Med Sci. 2014;6(12):618–624.
    1. Agarwal S.K., Mohareb S., Patel A. Systematic oral hydration with water is similar to parenteral hydration for prevention of contrast-induced nephropathy: an updated meta-analysis of randomised clinical data. Open Heart. 2015;2(1):e000317.
    1. Weisbord S.D., Gallagher M., Jneid H. Outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med. 2018;378(7):603–614.
    1. Davenport M.S., Khalatbari S., Cohan R.H., Ellis J.H. Contrast medium-induced nephrotoxicity risk assessment in adult inpatients: a comparison of serum creatinine level- and estimated glomerular filtration rate-based screening methods. Radiology. 2013;269(1):92–100.
    1. National Institute of Diabetes and Digestive and Kidney Diseases Creatinine standardization recommendations.
    1. Choyke P.L., Cady J., DePollar S.L., Austin H. Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients? Tech Urol. 1998;4(2):65–69.
    1. Too C.W., Ng W.Y., Tan C.C., Mahmood M.I., Tay K.H. Screening for impaired renal function in outpatients before iodinated contrast injection: Comparing the Choyke questionnaire with a rapid point-of-care-test. Eur J Radiol. 2015;84(7):1227–1231.
    1. Pannu N., Wiebe N., Tonelli M., Alberta Kidney Disease Network Prophylaxis strategies for contrast-induced nephropathy. JAMA. 2006;295(23):2765–2779.
    1. Kawashima S., Takano H., Iino Y., Takayama M., Takano T. Prophylactic hemodialysis does not prevent contrast-induced nephropathy after cardiac catheterization in patients with chronic renal insufficiency. Circ J. 2006;70(5):553–558.
    1. Cruz D.N., Goh C.Y., Marenzi G., Corradi V., Ronco C., Perazella M.A. Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review. Am J Med. 2012;125(1):66–78.e3.
    1. McDonald J.S., Katzberg R.W., McDonald R.J., Williamson E.E., Kallmes D.F. Is the presence of a solitary kidney an independent risk factor for acute kidney injury after contrast-enhanced CT? Radiology. 2016;278(1):74–81. doi: 10.1148/radiol.2015142676.
    1. Malyszko J., Kozlowska K., Kozlowski L., Malyszko J. Nephrotoxicity of anticancer treatment. Nephrol Dial Transplant. 2017;32(6):924–936.
    1. Kiski D., Stepper W., Brand E., Breithardt G., Reinecke H. Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial. Nephrol Dial Transplant. 2010;25(3):759–764.
    1. Onuigbo M.A.C., Onuigbo N.T.C. Does renin-angiotensin aldosterone system blockade exacerbate contrast-induced nephropathy in patients with chronic kidney disease? A prospective 50-month Mayo Clinic study. Ren Fail. 2008;30(1):67–72.
    1. Duan S.B., Zhou X.R., Peng Y.M. Prevention of radiocontrast-media-induced nephrotoxicity by perindopril and amlodipine in humans. China J Mod Med. 2003;13:32–36.
    1. Gupta R.K., Kapoor A., Tewari S., Sinha N., Sharma R.K. Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study. Indian Heart J. 1999;51(5):521–526.
    1. Hashemi M., Kharazi A., Shahidi S. Captopril for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a double-blind placebo controlled clinical trial. J Res Med Sci. 2005;10(5):305–308.
    1. Shemirani H., Pourrmoghaddas M. A randomized trial of saline hydration to prevent contrast-induced nephropathy in patients on regular captopril or furosemide therapy undergoing percutaneous coronary intervention. Saudi J Kidney Dis Transpl. 2012;23(2):280–285.
    1. Rim M.Y., Ro H., Kang W.C. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study. Am J Kidney Dis. 2012;60(4):576–582.
    1. Jo S.H., Lee J.M., Park J., Kim H.S. The impact of renin-angiotensin-aldosterone system blockade on contrast-induced nephropathy: a meta-analysis of 12 studies with 4,493 patients. Cardiology. 2015;130(1):4–14.
    1. United States Food and Drug Administration FDA revises warnings regarding use of diabetes medicine metformin in certain patients with reduced kidney function. Released April 8, 2016. Accessed June 4, 2019.
    1. Schwartz G.J., Work D.F. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol. 2009;4(11):1832–1843.
    1. Schwartz G.J., Muñoz A., Schneider M.F. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20(3):629–637.
    1. Staples A., LeBlond R., Watkins S., Wong C., Brandt J. Validation of the revised Schwartz estimating equation in a predominantly non-CKD population. Pediatr Nephrol. 2010;25(11):2321–2326.
    1. McDonald J.S., McDonald R.J., Tran C.L., Kolbe A.B., Williamson E.E., Kallmes D.F. Postcontrast acute kidney injury in pediatric patients: a cohort study. Am J Kidney Dis. 2018;72(6):811–818.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren